Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Techne (TECH) Return on Sales (2016 - 2025)

Bio-Techne has reported Return on Sales over the past 17 years, most recently at 0.13% for Q4 2025.

  • Quarterly results put Return on Sales at 0.13% for Q4 2025, up 1.0% from a year ago — trailing twelve months through Dec 2025 was 0.0% (down 13.0% YoY), and the annual figure for FY2025 was 0.01%, down 15.0%.
  • Return on Sales for Q4 2025 was 0.13% at Bio-Techne, down from 0.13% in the prior quarter.
  • Over the last five years, Return on Sales for TECH hit a ceiling of 44.87% in Q3 2022 and a floor of 0.67% in Q2 2022.
  • Median Return on Sales over the past 5 years was 0.14% (2025), compared with a mean of 2.31%.
  • Biggest five-year swings in Return on Sales: soared 4460bps in 2022 and later crashed -4468bps in 2023.
  • Bio-Techne's Return on Sales stood at 0.27% in 2021, then plummeted by -31bps to 0.18% in 2022, then crashed by -45bps to 0.1% in 2023, then rose by 17bps to 0.12% in 2024, then rose by 9bps to 0.13% in 2025.
  • The last three reported values for Return on Sales were 0.13% (Q4 2025), 0.13% (Q3 2025), and 0.33% (Q2 2025) per Business Quant data.